Novolin® 70/30 Premixed Human Insulin 10 mL Vial NPH/Regular Combination for Glycemic Control in Diabetes Management Therapy

Novolin® 70/30 Premixed Human Insulin 10 mL Vial NPH/Regular Combination for Glycemic Control in Diabetes Management Therapy

Novolin® 70/30 is a premixed insulin formulation used to help manage blood glucose levels in patients with diabetes mellitus. It combines intermediate-acting insulin isophane (NPH) with short-acting regular human insulin, therefore supporting both basal and mealtime glucose control. Moreover, healthcare providers commonly prescribe it for patients requiring simplified insulin regimens. In addition, the premixed ratio helps reduce the need for multiple daily injections. As a result, blood sugar management can become more consistent throughout the day. However, dosing must always be individualized and supervised by a healthcare professional. Meanwhile, the injectable vial format supports clinical and home administration under guidance.

Moreover, the combination of rapid and intermediate action helps control postprandial and fasting glucose levels. Therefore, it supports more stable glycemic control in diabetic patients. In addition, the 10 mL vial allows flexible dosing adjustments based on patient needs. Consequently, treatment plans can be tailored for better metabolic control. Furthermore, proper storage and handling are essential to maintain insulin effectiveness.

Features

• Premixed insulin combining NPH and regular human insulin for dual glucose control
• Helps manage both fasting and postprandial blood glucose levels
• Supports simplified insulin regimens, therefore reducing injection complexity
• 70 U/30 U ratio provides balanced intermediate and short-acting coverage
• 10 mL vial allows flexible dosing adjustments
• Suitable for type 1 and type 2 diabetes management under medical supervision
• Supports improved glycemic stability throughout the day
• Requires administration under healthcare professional guidance

Specifications

• Brand: Novolin®
• Type: Premixed insulin injection
• Composition: Human insulin isophane (NPH) / regular human insulin
• Concentration: 70 U / 30 U per mL
• Volume: 10 mL vial
• Use Case: Diabetes mellitus blood glucose management
• Administration Route: Subcutaneous injection
• Key Features: Dual-action insulin, premixed formulation, glycemic control support
• Application: Clinical and home insulin therapy under prescription

FAQs

How does it work?
It combines short-acting and intermediate-acting insulin for balanced glucose control.

Is it fast acting?
Part of it acts quickly, while the other provides longer coverage.

Can patients self-administer it?
Yes, but only under a healthcare provider’s instruction.

Is it for type 1 or type 2 diabetes?
It may be used for both, depending on medical guidance.

Product Notice
⛟ Returns may require restocking fee
🌡 Requires Refrigeration
Notice – This product is non-returnable